These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12706937)

  • 21. Is the tolerability of long-term thiazolidinedione therapy overstated?
    Malone RM; DeWalt DA; Pignone MP; Ives TJ
    J Am Coll Cardiol; 2003 Oct; 42(7):1334; author reply 1334-5. PubMed ID: 14522504
    [No Abstract]   [Full Text] [Related]  

  • 22. Rosiglitazone, but not pioglitazone, improves myocardial systolic function in type 2 diabetic patients: a tissue Doppler study.
    Pala S; Esen O; Akçakoyun M; Kahveci G; Kargin R; Tigen K; Karaahmet T; Açar G; Esen AM; Kirma C
    Echocardiography; 2010 May; 27(5):512-8. PubMed ID: 20412274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARgamma agonists: safety issues in heart failure.
    Tang WH; Maroo A
    Diabetes Obes Metab; 2007 Jul; 9(4):447-54. PubMed ID: 17587386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
    Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
    Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
    Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Mikhail NE; Wali S; Cope D
    Mayo Clin Proc; 2004 Apr; 79(4):571-2; author reply 575-7. PubMed ID: 15065626
    [No Abstract]   [Full Text] [Related]  

  • 27. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis.
    Yen FS; Wei JC; Chiu LT; Hsu CC; Hou MC; Hwu CM
    Liver Int; 2021 Jan; 41(1):110-122. PubMed ID: 33124143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiazolidinedione-induced congestive heart failure.
    Cheng AY; Fantus IG
    Ann Pharmacother; 2004 May; 38(5):817-20. PubMed ID: 15039476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
    Roussel R; Hadjadj S; Pasquet B; Wilson PW; Smith SC; Goto S; Tubach F; Marre M; Porath A; Krempf M; Bhatt DL; Steg PG
    Int J Cardiol; 2013 Aug; 167(4):1380-4. PubMed ID: 22560911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R
    Diabetes Care; 2004 Jan; 27(1):256-63. PubMed ID: 14693998
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined thiazolidinedione-insulin therapy: should we be concerned about safety?
    Scheen AJ
    Drug Saf; 2004; 27(12):841-56. PubMed ID: 15366973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.
    Lipscombe LL; Gomes T; Lévesque LE; Hux JE; Juurlink DN; Alter DA
    JAMA; 2007 Dec; 298(22):2634-43. PubMed ID: 18073359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazolidinediones and congestive heart failure--exacerbation or new onset of left ventricular dysfunction?
    Srivastava PM; Calafiore P; MacIsaac RJ; Hare DL; Jerums G; Burrell LM
    Diabet Med; 2004 Aug; 21(8):945-50. PubMed ID: 15270804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do thiazolidinediones cause congestive heart failure?
    Kennedy FP
    Mayo Clin Proc; 2003 Sep; 78(9):1076-7. PubMed ID: 12962160
    [No Abstract]   [Full Text] [Related]  

  • 37. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.
    Koro C; Barrett S; Qizilbash N
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of thiazolidinedione in patients with active bladder cancer.
    Li R; Metcalfe MJ; Ferguson JE; Mokkapati S; Nogueras González GM; Dinney CP; Navai N; McConkey DJ; Sahai SK; Kamat AM
    BJU Int; 2018 Feb; 121(2):244-251. PubMed ID: 28872778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Bell DS
    Mayo Clin Proc; 2004 Apr; 79(4):572; author reply 575-7. PubMed ID: 15065627
    [No Abstract]   [Full Text] [Related]  

  • 40. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N; McAfee AT; Koro C; Landon J; Arnold Chan K
    Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.